Medicamen Biotech standalone net profit rises 61.74% in the March 2018 quarter

Explore Business Standard

Sales rise 31.51% to Rs 29.30 crore
Net profit of Medicamen Biotech rose 61.74% to Rs 1.86 crore in the quarter ended March 2018 as against Rs 1.15 crore during the previous quarter ended March 2017. Sales rose 31.51% to Rs 29.30 crore in the quarter ended March 2018 as against Rs 22.28 crore during the previous quarter ended March 2017.For the full year,net profit rose 95.93% to Rs 10.11 crore in the year ended March 2018 as against Rs 5.16 crore during the previous year ended March 2017. Sales rose 35.23% to Rs 111.51 crore in the year ended March 2018 as against Rs 82.46 crore during the previous year ended March 2017.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
First Published: Jun 11 2018 | 4:55 PM IST